Emory Wright - Align Technology Ex Operations
| A1LG34 Stock | BRL 348.54 21.18 6.47% |
Insider
Emory Wright is Ex Operations of Align Technology
| Age | 53 |
| Phone | 408 470 1000 |
| Web | https://www.aligntech.com |
Emory Wright Latest Insider Activity
Tracking and analyzing the buying and selling activities of Emory Wright against Align Technology stock is an integral part of due diligence when investing in Align Technology. Emory Wright insider activity provides valuable insight into whether Align Technology is net buyers or sellers over its current business cycle. Note, Align Technology insiders must abide by specific rules, including filing SEC forms every time they buy or sell Align Technology'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Emory Wright over six months ago Acquisition by Emory Wright of 3533 shares of Align Technology subject to Rule 16b-3 | ||
Emory Wright over a year ago Acquisition by Emory Wright of 1070 shares of Align Technology subject to Rule 16b-3 | ||
Emory Wright over a year ago Exercise or conversion by Emory Wright of 544 shares of Align Technology subject to Rule 16b-3 |
Align Technology Management Efficiency
The company has return on total asset (ROA) of 0.0688 % which means that it generated a profit of $0.0688 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1001 %, meaning that it generated $0.1001 on every $100 dollars invested by stockholders. Align Technology's management efficiency ratios could be used to measure how well Align Technology manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Andre Schulten | The Procter Gamble | 52 | |
| Michael Pederson | Abbott Laboratories | 57 | |
| Elaine Leavenworth | Abbott Laboratories | 64 | |
| Ken Patel | The Procter Gamble | N/A | |
| James Young | Abbott Laboratories | N/A | |
| Jos Melo | Energisa SA | 60 | |
| Michael Dale | Abbott Laboratories | 59 | |
| Christopher Scoggins | Abbott Laboratories | 49 | |
| Shailesh Jejurikar | The Procter Gamble | 56 | |
| Mary Moreland | Abbott Laboratories | 57 | |
| David Tang | Western Digital | 58 | |
| Scott Leinenweber | Abbott Laboratories | 51 | |
| Wissam Jabre | Western Digital | 53 | |
| Daniel Ely | Randon SA Implementos | N/A | |
| Randel Woodgrift | Abbott Laboratories | 57 | |
| Peter Andrew | Western Digital | N/A | |
| Gene Zamiska | Western Digital | 61 | |
| Tiang Tan | Western Digital | 53 | |
| Sandro Trentin | Randon SA Implementos | N/A | |
| Maurcio Botelho | Energisa SA | 63 | |
| Fatima Francisco | The Procter Gamble | 55 | |
Management Performance
| Return On Equity | 0.1 | |||
| Return On Asset | 0.0688 |
Align Technology Leadership Team
Elected by the shareholders, the Align Technology's board of directors comprises two types of representatives: Align Technology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Align. The board's role is to monitor Align Technology's management team and ensure that shareholders' interests are well served. Align Technology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Align Technology's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Emory Wright, Ex Operations | ||
| Vamsi Pudipeddi, Chief VP | ||
| Simon Beard, MD VP | ||
| Jennifer OlsonWilk, Ex Success | ||
| John Morici, CFO Fin | ||
| Stuart Hockridge, Ex HR | ||
| Zelko Relic, Ex CTO | ||
| Shirley Stacy, VP Relations | ||
| Julie Coletti, Ex Officer | ||
| Joseph Hogan, CEO Pres |
Align Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Align Technology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.1 | |||
| Return On Asset | 0.0688 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 76.27 B | |||
| Shares Outstanding | 309.2 M | |||
| Price To Earning | 67.76 X | |||
| Price To Book | 4.19 X | |||
| Price To Sales | 21.83 X | |||
| Revenue | 3.95 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Align Stock
When determining whether Align Technology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Align Technology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Align Technology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Align Technology Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Align Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Align Stock refer to our How to Trade Align Stock guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.